How do novel agents affect allogeneic transplantation in CLL?
How far are we from a cure for CLL?
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Francesco Lo Coco
An update on two trials evaluating venetoclax in subsets of CLL
Information is key: why patients need to be empowered to learn about their disease